CPHI vs ICCM

CPHI exhibits severe financial distress, anchored by a weak Piotroski F-Score of 2/9 and a critical liquidity crisis. The company is operating with a negative gross margin (-3.18%), meaning it loses money on every product sold before operating expenses are even considered. With a current ratio of 0.32 and a quick ratio of 0.09, the firm lacks the liquid assets to cover its short-term obligations. This fundamental collapse is reflected in a catastrophic 5-year price decline of 99.8%.

ICCM presents a high-risk profile characterized by a stable but mediocre Piotroski F-Score of 4/9 and a complete lack of positive technical momentum. While the company shows strong top-line revenue growth of 46.20% and maintains a healthy current ratio of 2.61 with minimal debt, these are overshadowed by catastrophic price decay (-71.9% over 1 year) and severe operating losses (-329.63% margin). The disconnect between the current price ($0.32) and the analyst target ($2.73) suggests a speculative bet on future medical device adoption rather than current fundamental value.